The Animal Health Institute (AHI) today extended praise and appreciation to Congress for its bipartisan efforts in reauthorizing the Animal Drug User Fee Act (ADUFA). The bill, S. 622, was passed by the House of Representatives Monday evening and will now be sent to the President for his signature.
“Animal medicines play an important role in public health by providing veterinarians, pet owners and livestock producers with the tools needed to keep animals healthy,” said AHI President and CEO Alexander Mathews. “Reauthorization of ADUFA helps ensure continued access to innovative medicines that allow our pets to live longer, healthier lives and contribute to food safety by keeping food animals healthy.”
First approved in 2003, ADUFA allows the Food and Drug Administration to collect fees from animal health companies for the review of animal medicines. The additional resources allow the agency to meet performance goals that make the review of products more efficient while maintaining strict safety standards.
“We appreciate the bipartisan leadership on both sides of Capitol Hill that made this possible,” said Mathews. “Senators Tom Harkin (D-IA) and Lamar Alexander (R-TN), and Congressmen Joe Pitts (R-PA) and Frank Pallone (D-NJ) provided outstanding committee leadership. We also appreciate the work of Congressman John Shimkus (R-IL) who sponsored the bill in the House. Veterinarians, livestock and poultry producers and pet owners will all benefit from their efforts by having access to new and innovative medical advancements to treat and prevent diseases in animals. Consumers will reap the food safety benefits that result from the availability of additional tools to keep animals healthy.
The animal health industry is grateful to the U.S. Congress for recognizing the importance of this bill and its value to all Americans, and we look forward to the President signing it as soon as possible,” Mathews concluded.